Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
105.26
+3.24 (3.18%)
At close: Jun 1, 2026, 4:00 PM EDT
105.23
-0.03 (-0.03%)
After-hours: Jun 1, 2026, 4:10 PM EDT
Mesa Laboratories Earnings Call Transcripts
Fiscal Year 2026
-
The company highlighted its strong recurring revenue base, disciplined growth through both organic initiatives and strategic acquisitions, and resilience amid recent market headwinds. With a focus on regulated markets and continuous operational improvement, it expects accelerating growth as clinical trial activity rebounds.
Fiscal Year 2025
-
Biopharmaceutical development and calibration solutions showed strong growth, with regional disparities in clinical genomics due to China headwinds. Cost reductions and reinvestments are supporting commercialization and operational improvements, while M&A and APAC expansion remain strategic priorities.